Dimensional Fund Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-64,966
| Closed | -$48K | – | 3342 |
|
|
2024
Q4 | $48K | Sell |
64,966
-11,120
| -15% | -$13.4K | ﹤0.01% | 3297 |
|
|
2024
Q3 | $119K | Hold |
76,086
| – | – | ﹤0.01% | 3224 |
|
|
2024
Q2 | $128K | Buy |
76,086
+26,143
| +52% | +$46.9K | ﹤0.01% | 3219 |
|
|
2024
Q1 | $120K | Buy |
+49,943
| New | +$107K | ﹤0.01% | 3243 |
|
|
2023
Q4 | – | Sell |
-310,815
| Closed | -$339K | – | 3439 |
|
|
2023
Q3 | $339K | Sell |
310,815
-432,922
| -58% | -$760K | ﹤0.01% | 3116 |
|
|
2023
Q2 | $1.7M | Buy |
743,737
+24,555
| +3% | +$65.2K | ﹤0.01% | 2821 |
|
|
2023
Q1 | $1.75M | Buy |
719,182
+306,384
| +74% | +$702K | ﹤0.01% | 2770 |
|
|
2022
Q4 | $788 | Sell |
412,798
-50,390
| -11% | -$107K | ﹤0.01% | 2953 |
|
|
2022
Q3 | $1.11M | Sell |
463,188
-201,600
| -30% | -$558K | ﹤0.01% | 2857 |
|
|
2022
Q2 | $1.24M | Sell |
664,788
-204,823
| -24% | -$391K | ﹤0.01% | 2878 |
|
|
2022
Q1 | $1.82M | Buy |
869,611
+96,633
| +13% | +$268K | ﹤0.01% | 2855 |
|
|
2021
Q4 | $3.05M | Buy |
772,978
+277,540
| +56% | +$1.35M | ﹤0.01% | 2731 |
|
|
2021
Q3 | $2.38M | Sell |
495,438
-46,217
| -9% | -$190K | ﹤0.01% | 2810 |
|
|
2021
Q2 | $2.49M | Buy |
+541,655
| New | +$2.61M | ﹤0.01% | 2817 |
|
|
2021
Q1 | – | Sell |
-16,778
| Closed | -$57K | – | 3420 |
|
|
2020
Q4 | $57K | Buy |
+16,778
| New | +$32K | ﹤0.01% | 3311 |
|
|
2020
Q2 | – | Sell |
-32,900
| Closed | -$64K | – | 3353 |
|
|
2020
Q1 | $64K | Buy |
32,900
+19,000
| +137% | +$56.6K | ﹤0.01% | 3303 |
|
|
2019
Q4 | $58K | Buy |
+13,900
| New | +$53.5K | ﹤0.01% | 3341 |
|
|
2016
Q2 | – | Sell |
-31,101
| Closed | -$372K | – | 3301 |
|
|
2016
Q1 | $372K | Sell |
31,101
-2,501
| -7% | -$26.2K | ﹤0.01% | 3093 |
|
|
2015
Q4 | $447K | Hold |
33,602
| – | – | ﹤0.01% | 3110 |
|
|
2015
Q3 | $361K | Hold |
33,602
| – | – | ﹤0.01% | 3173 |
|
|
2015
Q2 | $270K | Buy |
+33,602
| New | +$247K | ﹤0.01% | 3217 |
|
Other funds holding LXRX
AG
SL
SSA
